{
"NDC": {
"NDCCode": "60687-560-21",
"PackageDescription": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21) / 1 TABLET in 1 BLISTER PACK (60687-560-11) ",
"NDC11Code": "60687-0560-21",
"ProductNDC": "60687-560",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Repaglinide",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Repaglinide",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20200917",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA203820",
"LabelerName": "American Health Packaging",
"SubstanceName": "REPAGLINIDE",
"StrengthNumber": "1",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Glinide [EPC], Potassium Channel Antagonists [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-10-24",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20200917",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}